Stay updated on Ixazomib Combo in Relapsed/Refractory MM Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page.

Latest updates to the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThis update only changes the site’s displayed revision/version indicator from v3.5.0 to v3.5.3, with no indication of changes to the clinical trial’s history or study details.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry, v3.5.0, was added to the history and revision v3.4.3 was removed.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Oversight and Study Status entries on 2026-03-05 and updated the record to Revision v3.4.3; the previous revision v3.4.2 (2025-09-09) was removed.SummaryDifference0.6%

- Check92 days agoChange DetectedA new revision entry 'Revision: v3.4.2' was added to the Study Record Versions, replacing the previous v3.4.1 entry. This update appears to be a release-note style change rather than a modification of study data.SummaryDifference0.1%

- Check99 days agoChange DetectedThe Record History page shows a new revision entry, v3.4.1, and removes the previous revision, v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check106 days agoChange DetectedThe page now includes a glossary toggle and color-coded change highlights (green for additions, red for deletions) with updated revision labels. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

Stay in the know with updates to Ixazomib Combo in Relapsed/Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page.